Floatz logo

Tirzepatide

Non-alcoholic Steatohepatitis

Dr Adnan Aghaprotein_peptidePhase 2Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
89/ 100

Competitive context

17 Active assets in the Non-alcoholic Steatohepatitis cohort.

Asset / SponsorPhaseRating
Semaglutide
Cascade Pharmaceuticals, Inc
Phase 4BBB
URSODEOXYCHOLIC ACID
Kafrelsheikh University
Phase 4BB
Dapagliflozin
Cairo University
Phase 3BB
pf-06865571
Pfizer
Phase 2BB
Cotadutide
AstraZeneca
Phase 2BB

View all 40 →

Same molecule, other indications

Tirzepatide is also rated in:

type 1 diabetes mellitusDormant
BBB
Indicative ·
78 / 100
View asset →
psoriatic arthritisDormant
BBB
Indicative ·
74 / 100
View asset →
diastolic heart failureDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →